Jagsonpal Pharmaceuticals Investor Relations Material
Latest events
Q4 24/25
Jagsonpal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jagsonpal Pharmaceuticals Limited
Access all reports
Jagsonpal Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded generic formulations. The company offers a range of dosage forms including tablets, capsules, syrups, and injectables across therapeutic segments such as gynecology, orthopedics, dermatology, and general medicine. It serves domestic and international markets through an established distribution network and field force. The company is headquartered in New Delhi, India, and its shares are listed on the BSE.
Key slides for Jagsonpal Pharmaceuticals Limited
Q4 24/25
Jagsonpal Pharmaceuticals Limited
Q4 24/25
Jagsonpal Pharmaceuticals Limited
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
JAGSNPHARM
Country
🇮🇳 India